Performance of SAGE Sage Therapeutic | -77.7% in 12m
Compare SAGE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Sage Therapeutic with its related Sector/Index XBI
Performance Duell SAGE vs XBI
| TimeFrame | SAGE | XBI |
|---|---|---|
| 1 Day | -2.58% | -1.52% |
| 1 Week | -1.68% | 3.45% |
| 1 Month | -6.92% | 7.71% |
| 3 Months | -49.7% | -2.11% |
| 6 Months | -38.9% | 25.51% |
| 12 Months | -77.7% | 6.37% |
| YTD | -48.0% | 1.05% |
| Rel. Perf. 1m | -2.17 | |
| Rel. Perf. 3m | -6.24 | |
| Rel. Perf. 6m | -7.30 | |
| Rel. Perf. 12m | -15.58 |
Is Sage Therapeutic a good stock to buy?
No, based on ValueRay Fundamental Analyses, Sage Therapeutic (NASDAQ:SAGE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -52.82 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAGE as of May 2024 is 7.81. This means that SAGE is currently overvalued and has a potential downside of -33.25% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAGE as of May 2024 is 7.81. This means that SAGE is currently overvalued and has a potential downside of -33.25% (Sold with Premium).
Is SAGE a buy, sell or hold?
- Strong Buy: 1
- Buy: 3
- Hold: 16
- Sell: 1
- Strong Sell: 0
Values above 0%: SAGE is performing better - Values below 0%: SAGE is underperforming
Compare SAGE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.33% | -12.69% | -57.23% | -107.00% |
| US NASDAQ 100 | QQQ | -3.87% | -13.01% | -56.41% | -115.00% |
| US Dow Jones Industrial 30 | DIA | -3.04% | -13.09% | -54.41% | -99.67% |
| German DAX 40 | DBXD | -1.28% | -11.89% | -55.93% | -94.42% |
| UK FTSE 100 | ISFU | -3.18% | -16.72% | -55.80% | -93.02% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.79% | -11.44% | -42.27% | -69.98% |
| Hongkong Hang Seng | HSI | -5.41% | -30.20% | -43.98% | -72.29% |
| Japan Nikkei 225 | EXX7 | -2.05% | -6.42% | -50.43% | -89.46% |
| India NIFTY 50 | INDA | -4.79% | -10.84% | -56.52% | -106.37% |
| Brasil Bovespa | EWZ | -2.12% | -12.16% | -37.11% | -89.98% |
SAGE Sage Therapeutic vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.68% | -10.23% | -57.45% | -115.13% |
| Consumer Discretionary | XLY | -2.02% | -10.62% | -46.28% | -97.32% |
| Consumer Staples | XLP | -2.44% | -13.50% | -53.18% | -83.23% |
| Energy | XLE | -2.88% | -7.80% | -53.06% | -102.87% |
| Financial | XLF | -3.26% | -13.97% | -61.36% | -110.72% |
| Health Care | XLV | -3.57% | -12.60% | -53.95% | -91.15% |
| Industrial | XLI | -1.40% | -10.40% | -58.63% | -105.98% |
| Materials | XLB | -2.02% | -10.46% | -54.96% | -98.27% |
| Real Estate | XLRE | -4.19% | -15.40% | -48.58% | -87.63% |
| Technology | XLK | -4.74% | -13.44% | -55.26% | -115.96% |
| Utilities | XLU | -3.18% | -19.81% | -57.14% | -90.33% |
| Aerospace & Defense | XAR | -2.45% | -15.38% | -54.48% | -101.80% |
| Biotech | XBI | -5.13% | -14.63% | -64.45% | -84.02% |
| Homebuilder | XHB | -1.36% | -13.26% | -69.45% | -128.50% |
| Retail | XRT | -3.76% | -14.38% | -59.78% | -102.84% |
Does Sage Therapeutic outperform its market, is SAGE a Sector Leader?
No, over the last 12 months Sage Therapeutic (SAGE) made -77.65%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months SAGE made -49.72%, while XBI made -2.11%.
No, over the last 12 months Sage Therapeutic (SAGE) made -77.65%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.37%.
Over the last 3 months SAGE made -49.72%, while XBI made -2.11%.
| Period | SAGE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.92% | 7.71% | 5.77% |
| 3 Months | -49.72% | -2.11% | 6.32% |
| 12 Months | -77.65% | 6.37% | 29.35% |